Table 2 The detailed information of subjects in cases
Characteristics | AML group | Healthy controls | P values |
|---|---|---|---|
Mean age (years) | 41.27 ± 3.45 | 40.43 ± 4.07 | 0.367 |
Gender | 0.874 | ||
Male | 48 (47.06) | 52 (48.15) | |
Female | 54 (52.94) | 56 (51.85) | |
BMI (kg/m2) | 23.32 ± 2.29 | 22.19 ± 1.96 | 0.712 |
WBC (count × 109/L) | < 0.001 | ||
< 4 | 39 (38.24) | 5 (4.63) | |
4–10 | 13 (12.74) | 79 (73.15) | |
> 10 | 50 (49.02) | 16 (14.81) | |
FAB classification | – | – | |
M0 | 2 (1.96) | – | |
M1 | 4 (3.92) | ||
M2 | 21 (20.59) | ||
M3 | 32 (31.37) | ||
M4 | 19 (18.63) | ||
M5 | 15 (14.71) | ||
M6 | 5 (4.90) | ||
M7 | 4 (3.92) | ||
Immunophenotype | – | – | |
T cell type | 21 (20.59) | ||
Pre-B cell type | 81 (79.41) | ||
Lymphadenopathy | – | ||
Yes | 20 (19.61) | 0 (0.00) | |
No | 82 (80.39) | 108 (100.00) | |